Τίτλος:
Cystic fibrosis drug approved for patients aged 6-11 years worked well in clinical practice
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Συγγραφείς:
Loukou, I.
Petrocheilou, A.
Moustaki, M.
Katsagoni, C.N.
Douros, K.
Περιοδικό:
Acta Paediatrica, International Journal of Paediatrics
Εκδότης:
Wiley-Blackwell Publishing Ltd
Λέξεις-κλειδιά:
cystic fibrosis transmembrane conductance regulator; ivacaftor plus lumacaftor; cystic fibrosis transmembrane conductance regulator; drug, Article; body mass; cataract; child; clinical article; clinical practice; cystic fibrosis; drug efficacy; drug safety; drug withdrawal; female; follow up; forced expiratory volume; Greece; human; liver disease; longitudinal study; lung function; male; nutritional status; observational study; priority journal; prospective study; Pseudomonas infection; spirometry, Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Pharmaceutical Preparations
